Korro Bio (KRRO) Earnings Date & Reports

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

KRRO is expected to report earnings to fall 26.63% to -124 cents per share on August 18

Q2'26

Est.

$-1.24

Q1'26

Beat

by $1.68

Q4'25

Missed

by $2.90

Q3'25

Beat

by $0.35

Q2'25

Missed

by $0.57

The last earnings report on May 07 showed earnings per share of -169 cents, beating the estimate of -336 cents. With 315.46K shares outstanding, the current market capitalization sits at 167.45M.

View a ticker or compare two or three

Compare

KRRO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for KRRO